Skip to main content
Top
Published in: Trials 1/2013

Open Access 01-12-2013 | Study protocol

Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design

Authors: Gabriela J Prutsky, Juan Pablo Domecq, Patricia J Erwin, Matthias Briel, Victor M Montori, Elie A Akl, Joerg J Meerpohl, Dirk Bassler, Stefan Schandelmaier, Stephen D Walter, Qi Zhou, Pablo Alonso Coello, Lorenzo Moja, Martin Walter, Kristian Thorlund, Paul Glasziou, Regina Kunz, Ignacio Ferreira-Gonzalez, Jason Busse, Xin Sun, Annette Kristiansen, Benjamin Kasenda, Osama Qasim-Agha, Gennaro Pagano, Hector Pardo-Hernandez, Gerard Urrutia, Mohammad Hassan Murad, Gordon Guyatt

Published in: Trials | Issue 1/2013

Login to get access

Abstract

Background

Randomized control trials (RCTs) stopped early for benefit (truncated RCTs) are increasingly common and, on average, overestimate the relative magnitude of benefit by approximately 30%. Investigators stop trials early when they consider it is no longer ethical to enroll patients in a control group. The goal of this systematic review is to determine how investigators of ongoing or planned RCTs respond to the publication of a truncated RCT addressing a similar question.

Methods/design

We will conduct systematic reviews to update the searches of 210 truncated RCTs to identify similar trials ongoing at the time of publication, or started subsequently, to the truncated trials ('subsequent RCTs’). Reviewers will determine in duplicate the similarity between the truncated and subsequent trials. We will analyze the epidemiology, distribution, and predictors of subsequent RCTs. We will also contact authors of subsequent trials to determine reasons for beginning, continuing, or prematurely discontinuing their own trials, and the extent to which they rely on the estimates from truncated trials.

Discussion

To the extent that investigators begin or continue subsequent trials they implicitly disagree with the decision to stop the truncated RCT because of an ethical mandate to administer the experimental treatment. The results of this study will help guide future decisions about when to stop RCTs early for benefit.
Appendix
Available only for authorised users
Literature
2.
go back to reference Zannad F, GattisStough W, McMurray JJ, Remme WJ, Pitt B, Borer JS, Geller NL, Pocock SJ:When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail. 2012, 5: 294-302. 10.1161/CIRCHEARTFAILURE.111.965707.CrossRefPubMed Zannad F, GattisStough W, McMurray JJ, Remme WJ, Pitt B, Borer JS, Geller NL, Pocock SJ:When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail. 2012, 5: 294-302. 10.1161/CIRCHEARTFAILURE.111.965707.CrossRefPubMed
3.
go back to reference DAMOCLES Study Group: NHS Health Technology Assessment Programme: A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005, 365: 711-722.CrossRef DAMOCLES Study Group: NHS Health Technology Assessment Programme: A proposed charter for clinical trial data monitoring committees: helping them to do their job well. Lancet. 2005, 365: 711-722.CrossRef
4.
go back to reference Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH:Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med. 2007, 146: 878-881. 10.7326/0003-4819-146-12-200706190-00009.CrossRefPubMed Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH:Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med. 2007, 146: 878-881. 10.7326/0003-4819-146-12-200706190-00009.CrossRefPubMed
5.
go back to reference Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH:Randomized trials stopped early for benefit: a systematic review. JAMA. 2005, 294: 2203-2209. 10.1001/jama.294.17.2203.CrossRefPubMed Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM, Bucher HC, Schünemann HJ, Meade MO, Cook DJ, Erwin PJ, Sood A, Sood R, Lo B, Thompson CA, Zhou Q, Mills E, Guyatt GH:Randomized trials stopped early for benefit: a systematic review. JAMA. 2005, 294: 2203-2209. 10.1001/jama.294.17.2203.CrossRefPubMed
6.
go back to reference Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, STOPIT-2 Study Group , Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ, Lutz K, Ribic CM, Vale N:Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. Jama. 2010, 303: 1180-1187. 10.1001/jama.2010.310.CrossRefPubMed Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, STOPIT-2 Study Group , Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ, Lutz K, Ribic CM, Vale N:Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. Jama. 2010, 303: 1180-1187. 10.1001/jama.2010.310.CrossRefPubMed
8.
go back to reference Cochrane Handbook for Systematic Reviews of Interventions: Book Cochrane Handbook for Systematic Reviews of Interventions. 2011, Oxford: The Cochrane Collaboration: Higgins J, Green S Cochrane Handbook for Systematic Reviews of Interventions: Book Cochrane Handbook for Systematic Reviews of Interventions. 2011, Oxford: The Cochrane Collaboration: Higgins J, Green S
9.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D:The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009, 62: e1-34. 10.1016/j.jclinepi.2009.06.006.CrossRefPubMed Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D:The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009, 62: e1-34. 10.1016/j.jclinepi.2009.06.006.CrossRefPubMed
10.
go back to reference Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A:Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value Health. 2011, 14: 429-437. 10.1016/j.jval.2011.01.011.CrossRefPubMed Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A:Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. Value Health. 2011, 14: 429-437. 10.1016/j.jval.2011.01.011.CrossRefPubMed
11.
go back to reference Sydes MR, Altman DG, Babiker AB, Parmar MK, Spiegelhalter DJ: DAMOCLES Group: Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Clin Trials. 2004, 1: 48-59. 10.1191/1740774504cn003oa.CrossRefPubMed Sydes MR, Altman DG, Babiker AB, Parmar MK, Spiegelhalter DJ: DAMOCLES Group: Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study. Clin Trials. 2004, 1: 48-59. 10.1191/1740774504cn003oa.CrossRefPubMed
12.
go back to reference Bassler D, Montori VM, Briel M, Glasziou P, Walter SD, Ramsay T, Guyatt G:Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it?. Stat Methods Med Res. 2013, 22: 159-168. 10.1177/0962280211432211.CrossRefPubMed Bassler D, Montori VM, Briel M, Glasziou P, Walter SD, Ramsay T, Guyatt G:Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it?. Stat Methods Med Res. 2013, 22: 159-168. 10.1177/0962280211432211.CrossRefPubMed
Metadata
Title
Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design
Authors
Gabriela J Prutsky
Juan Pablo Domecq
Patricia J Erwin
Matthias Briel
Victor M Montori
Elie A Akl
Joerg J Meerpohl
Dirk Bassler
Stefan Schandelmaier
Stephen D Walter
Qi Zhou
Pablo Alonso Coello
Lorenzo Moja
Martin Walter
Kristian Thorlund
Paul Glasziou
Regina Kunz
Ignacio Ferreira-Gonzalez
Jason Busse
Xin Sun
Annette Kristiansen
Benjamin Kasenda
Osama Qasim-Agha
Gennaro Pagano
Hector Pardo-Hernandez
Gerard Urrutia
Mohammad Hassan Murad
Gordon Guyatt
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Trials / Issue 1/2013
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-14-335

Other articles of this Issue 1/2013

Trials 1/2013 Go to the issue